Searched for
ACTAVIS MANUFACTURING
Lupin appoints Dr Ranjana Pathak as chief quality officerDr. Ranjana Pathak appointed Lupin's chief quality officer, succeeding Johnny Mikell. With 30 years of experience, she led quality at Cipla...- Intas & Dr Reddy's in race with PEs to buy US' AthenexAthenex, which is into the development of cell therapies to treat cancers, had hired investment advisory firm Cowen Inc to run a formal pro...
- Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
- Aurobindo Pharma to buy Portugal's Generis for 135 mn euroAurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Israel's Teva buys Allergan generic drug company for $40.5 billionTeva Pharmaceutical Industries Ltd. says it is purchasing Dublin-based Allergan PLC's generic pharmaceuticals business for $40.5 billion.
- Aurobindo, Actavis recall Gabapentin capsulesThe drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.
- Aurobindo Pharma eyes $2 billion revenues in FY15The consolidated revenue (net) from operations was higher over the previous year by 38.3 per cent at nearly Rs 8,100 crore during 2013-14.
- Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
- Vivimed acquires Actavis Pharma's facility for Rs 122 croreVivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Regenix beefs Board, goes for out-of-court settlement with StridesRegenix promoter Dr A Ramamurthy made waves in the pharma circuit in 2007. That was when the physician-entrepreneur sold the marketing righ...
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Orchid gets USFDA nod to launch TerbinafineOrchid Chemicals and Pharmaceuticals Ltd on Friday said it has received tentative approval from US Food and Drug Administration.
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Merck Generics valuation to be hit as Duoneb patent endsMerck Generics' lucrative US subsidiary Dey, a specialty pharmaceutical company focused on the development of new drug delivery systems for...
- Actavis acquires Sanmar subsidiaryActavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Actavis acquires Grandix manufacturing plantActavis Group, an international generic pharmaceuticals company has acquired the three-year-old manufacturing factory of Chennai-based Gran...
Load More
